Additionally, it has been reported to work in conjunction with vascular endothelial growth factor receptors (VEGFR)‐2 and VEGFR‐3, influencing hepatic vascular development and potentially contributing to HCC onset in patients with chronic hepatitis C [25]. The gene discussed is FLT4; the disease is chronic hepatitis C virus infection.